Loading [Contrib]/a11y/accessibility-menu.js
Search Advanced

Mathematical Biosciences and Engineering

2015, Volume 12, Issue 5: 1037-1053. doi: 10.3934/mbe.2015.12.1037
Previous Article Next Article

Analysis of a cancer dormancy model and control of immuno-therapy

  • 1.
    Department of Mathematics, Iowa State University, Ames, IA 50011
  • Received: 01 July 2014 Accepted: 29 June 2018 Published: 01 June 2015

  • MSC : Primary: 92C50, 93C10; Secondary: 93D05.

  • The goal of this paper is to analyze a model of cancer-immune system interactions from [16], and to show how the introduction of control in this model can dramatically improve the hypothetical patient response and in effect prevent the cancer from growing. We examine all the equilibrium points of the model and classify them according to their stability properties. We identify an equilibrium point corresponding to a survivable amount of cancer cells which are exactly balanced by the immune response. This situation corresponds to cancer dormancy. By using Lyapunov stability theory we estimate the region of attraction of this equilibrium and propose two control laws which are able to stabilize the system effectively, improving the results of [16]. Ultimately, the analysis presented in this paper reveals that a slower, continuous introduction of antibodies over a short time scale, as opposed to mere inoculation, may lead to more efficient and safer treatments.

    Citation: Ben Sheller, Domenico D'Alessandro. Analysis of a cancer dormancy model and control of immuno-therapy[J]. Mathematical Biosciences and Engineering, 2015, 12(5): 1037-1053. doi: 10.3934/mbe.2015.12.1037

    Related Papers:

    [1] Rujing Zhao, Xiulan Lai . Evolutionary analysis of replicator dynamics about anti-cancer combination therapy. Mathematical Biosciences and Engineering, 2023, 20(1): 656-682. doi: 10.3934/mbe.2023030
    [2] Pedro José Gutiérrez-Diez, Jose Russo . Design of personalized cancer treatments by use of optimal control problems: The case of chronic myeloid leukemia. Mathematical Biosciences and Engineering, 2020, 17(5): 4773-4800. doi: 10.3934/mbe.2020261
    [3] Lu Gao, Yuanshun Tan, Jin Yang, Changcheng Xiang . Dynamic analysis of an age structure model for oncolytic virus therapy. Mathematical Biosciences and Engineering, 2023, 20(2): 3301-3323. doi: 10.3934/mbe.2023155
    [4] Erin N. Bodine, K. Lars Monia . A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma. Mathematical Biosciences and Engineering, 2017, 14(4): 881-899. doi: 10.3934/mbe.2017047
    [5] Haifeng Zhang, Jinzhi Lei . Optimal treatment strategy of cancers with intratumor heterogeneity. Mathematical Biosciences and Engineering, 2022, 19(12): 13337-13373. doi: 10.3934/mbe.2022625
    [6] Laurenz Göllmann, Helmut Maurer . Optimal control problems with time delays: Two case studies in biomedicine. Mathematical Biosciences and Engineering, 2018, 15(5): 1137-1154. doi: 10.3934/mbe.2018051
    [7] Cassidy K. Buhler, Rebecca S. Terry, Kathryn G. Link, Frederick R. Adler . Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives. Mathematical Biosciences and Engineering, 2021, 18(5): 6305-6327. doi: 10.3934/mbe.2021315
    [8] Gesham Magombedze, Winston Garira, Eddie Mwenje . Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: The role of fusion inhibitors in HAART. Mathematical Biosciences and Engineering, 2008, 5(3): 485-504. doi: 10.3934/mbe.2008.5.485
    [9] Ghassen Haddad, Amira Kebir, Nadia Raissi, Amira Bouhali, Slimane Ben Miled . Optimal control model of tumor treatment in the context of cancer stem cell. Mathematical Biosciences and Engineering, 2022, 19(5): 4627-4642. doi: 10.3934/mbe.2022214
    [10] Judy Day, Jonathan Rubin, Gilles Clermont . Using nonlinear model predictive control to find optimal therapeutic strategies to modulate inflammation. Mathematical Biosciences and Engineering, 2010, 7(4): 739-763. doi: 10.3934/mbe.2010.7.739
  • The goal of this paper is to analyze a model of cancer-immune system interactions from [16], and to show how the introduction of control in this model can dramatically improve the hypothetical patient response and in effect prevent the cancer from growing. We examine all the equilibrium points of the model and classify them according to their stability properties. We identify an equilibrium point corresponding to a survivable amount of cancer cells which are exactly balanced by the immune response. This situation corresponds to cancer dormancy. By using Lyapunov stability theory we estimate the region of attraction of this equilibrium and propose two control laws which are able to stabilize the system effectively, improving the results of [16]. Ultimately, the analysis presented in this paper reveals that a slower, continuous introduction of antibodies over a short time scale, as opposed to mere inoculation, may lead to more efficient and safer treatments.


    [1] Cancer Research, 73 (2013), 583-594.
    [2] Physica D, 208 (2005), 220-235.
    [3] Annu. Rev. Immunol., 22 (2004), 329-360.
    [4] Bull. Math. Biol., 73 (2011), 2-32.
    [5] Nature, 440 (2006), 1222-1226.
    [6] IEEE Transactions on Automatic Control, 30 (1985), 747-755.
    [7] Springer Verlag, Heidelberg-Berlin, 1967.
    [8] Prentice-Hall Information and System Sciences Series. Prentice-Hall, Inc., Englewood Cliffs, N.J., 1980.
    [9] John Wiley and Sons, 1995.
    [10] Cybern. syst. Anal, 23 (1988), 556-564.
    [11] Bull. Math. Biol, 56 (1994), 295-321.
    [12] Discrete and Continuous Dynamical Systems, Series B, 18 (2013), 1031-1051.
    [13] Journal of Mathematical Biology, 64 (2012), 557-577.
    [14] J. of the National Cancer Institute, 58 (1977), 1735-1741.
    [15] Cancer Research, 48 (1988), 7067-7071.
    [16] Leukemia and Lymphoma, 46 (2005), 313-327.
    [17] PNAS, 100 (2003), 8372-8377.
    [18] SIAM J. Control Optim., 48 (2010), 4377-4394.
    [19] Prentice-Hall, Advanced Reference Series (Engineering), 1989.
    [20] Nature Reviews Cancer, 12 (2012), 278-287.
    [21] Biophysics, 24 (1980), 917-923.
    [22] IPSJ Trans Math Model Appl., 47 (2006), 61-67.
    [23] Automatica, 21 (1985), 69-80.
    [24] Systems Biology of Tumor Dormancy, Springer, New York, 2013.
    [25] Israel Jerusalem Academic Press, 1962.
    [26] the Netherlands, Noordhoff, 1964.
    [27] January 7-10, 2013.

  • This article has been cited by:

    1. Frank C. Cackowski, Russell S. Taichman, Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation, 2019, 119, 87563282, 82, 10.1016/j.bone.2018.02.025
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Mathematical Biosciences and Engineering
4.4

Metrics

Article views(2563) PDF downloads(503) Cited by(1)

Preview PDF
Download XML
Export Citation
Article outline
Abstract
References

Other Articles By Authors

Related pages

Tools

Copyright © AIMS Press

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog